Skip to content

Clinical trials

Terminated Hepatitis B trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Status: Terminated Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20074
20083
20122
20141
20151
20183
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assembly Biosciences2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Novartis2
Pharmasset2
Arrowhead Pharmaceuticals1
Beckman Coulter, Inc.1
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
GlaxoSmithKline1
New Discovery LLC1
Rockefeller University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B19
Hepatitis B, Chronic4
Hepatitis C4
Hepatitis, Chronic2
Liver Diseases2
Liver Neoplasms2
Non-alcoholic Fatty Liver Disease2
Acquired Immunodeficiency Syndrome1
Acute Kidney Injury1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.